These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India. Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA Front Public Health; 2022; 10():967447. PubMed ID: 36276377 [TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?]. Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F; Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811 [TBL] [Abstract][Full Text] [Related]
5. High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya. Awandu SS; Ochieng Ochieng A; Onyango B; Magwanga RO; Were P; Atieno Ochung' A; Okumu F; Oloo MA; Katieno JS; Lidechi S; Ogutu F; Awuor D; Kirungu JN; Orata F; Achieng J; Oure B; Nyunja R; Muok EMO; Munga S; Estambale B PLoS One; 2022; 17(12):e0272751. PubMed ID: 36548358 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19. Esposito S; Neglia C; Affanni P; Colucci ME; Argentiero A; Veronesi L; Messina G; Deolmi M; Principi N; Front Public Health; 2021; 9():628098. PubMed ID: 34249830 [No Abstract] [Full Text] [Related]
7. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States. Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data. Cabezón-Gutiérrez L; Custodio-Cabello S; Palka-Kotlowska M; Oliveros-Acebes E; García-Navarro MJ; Khosravi-Shahi P Cancer Treat Rev; 2020 Nov; 90():102102. PubMed ID: 32947121 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India. Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran. Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R Front Public Health; 2022; 10():832003. PubMed ID: 35400056 [TBL] [Abstract][Full Text] [Related]
11. The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19. Qin X; Shen J; Dai E; Li H; Tang G; Zhang L; Hou X; Lu M; Wu X; Duan S; Zhang J; Tsoi MF; Jiang P; Li Y BMC Immunol; 2021 Feb; 22(1):14. PubMed ID: 33596826 [TBL] [Abstract][Full Text] [Related]
12. Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021. Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D BMC Infect Dis; 2022 Feb; 22(1):174. PubMed ID: 35189840 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain. Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269 [TBL] [Abstract][Full Text] [Related]
14. Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence. Heyming TW; Sanger T; Tongol A; Schomberg J; Bacon K; Lara B West J Emerg Med; 2021 Apr; 22(3):565-571. PubMed ID: 34125028 [TBL] [Abstract][Full Text] [Related]
15. [SARS-CoV-2 seroprevalence among workers in a hospital in Madrid.]. Pérez-García F; Pérez-Zapata A; Arcos Varela N; de la Mata Herrera M; Ortiz García M; Simón Ramos E; Calero Barzano C; Clemente García B; García Miranda L; Martín Soto L; Ropero Martínez M; Barrabés Bayascas RM; Cuadros-González J Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34675168 [TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of seroprevalence in a cohort of university students of Rome (Italy) between September 2020 and July 2021. Ulivieri A; Morgante A; Magi F; Salehi LB; Lavra L Epidemiol Prev; 2022; 46(5-6):367-375. PubMed ID: 36628641 [TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts. Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study. Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107 [TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India. Agarwal D; Patil R; Roy S; Kaur H; Mehandale S; Bavdekar A; Nair H; Juvekar S; Dayma G; J Glob Health; 2023 Apr; 13():06011. PubMed ID: 37079274 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of SARS -CoV-2 IgG/IgM antibodies among patients in Zakho City, Kurdistan, Iraq. Saeed AY; Assafi MS; Othman HE; Shukri HM J Infect Dev Ctries; 2022 Jul; 16(7):1126-1130. PubMed ID: 35905016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]